Bellerophon Therapeutics, Inc. Operating Lease, Liability, Current
Bellerophon Therapeutics, Inc. had Operating Lease, Liability, Current of $8.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2023-11-14
- 2023-03-31: Operating Lease, Liability, Current $8.00K.
- 2022-12-31: Operating Lease, Liability, Current $203.00K.
- 2022-09-30: Operating Lease, Liability, Current $396.00K.
- 2022-06-30: Operating Lease, Liability, Current $586.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2023-03-31 | $8.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $203.00K 10-Q · filed 2023-11-14 |
| 2022-09-30 | $396.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $586.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $765.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $752.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $740.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $728.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $716.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $704.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $692.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $680.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $669.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $658.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $647.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $556.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $547.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-K · filed 2020-04-06 |